| 000 | 01807 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517182047.0 | ||
| 264 | 0 | _c20181119 | |
| 008 | 201811s 0 0 eng d | ||
| 022 | _a1366-5928 | ||
| 024 | 7 |
_a10.1080/00498254.2017.1396379 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYasumuro, Osamu | |
| 245 | 0 | 0 |
_aChanges in gefitinib, erlotinib and osimertinib pharmacokinetics under various gastric pH levels following oral administration of omeprazole and vonoprazan in rats. _h[electronic resource] |
| 260 |
_bXenobiotica; the fate of foreign compounds in biological systems _cNov 2018 |
||
| 300 |
_a1106-1112 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAcrylamides |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAniline Compounds |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 |
_aErlotinib Hydrochloride _xblood |
| 650 | 0 | 4 | _aGefitinib |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOmeprazole _xadministration & dosage |
| 650 | 0 | 4 |
_aPiperazines _xblood |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacokinetics |
| 650 | 0 | 4 |
_aProton Pump Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aPyrroles _xadministration & dosage |
| 650 | 0 | 4 |
_aQuinazolines _xblood |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSulfonamides _xadministration & dosage |
| 700 | 1 | _aUchida, Shinya | |
| 700 | 1 | _aKashiwagura, Yasuharu | |
| 700 | 1 | _aSuzuki, Ayae | |
| 700 | 1 | _aTanaka, Shimako | |
| 700 | 1 | _aInui, Naoki | |
| 700 | 1 | _aWatanabe, Hiroshi | |
| 700 | 1 | _aNamiki, Noriyuki | |
| 773 | 0 |
_tXenobiotica; the fate of foreign compounds in biological systems _gvol. 48 _gno. 11 _gp. 1106-1112 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/00498254.2017.1396379 _zAvailable from publisher's website |
| 999 |
_c27710039 _d27710039 |
||